{"result": "(\"entity\"<|>HEPATITIS<|>EVENT<|>Hepatitis is a medical condition characterized by inflammation of the liver, often due to viral infections or other factors affecting liver health.)\n##\n(\"entity\"<|>LIVER CIRRHOSIS<|>EVENT<|>Liver cirrhosis is a late stage of scarring (fibrosis) of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcoholism.)\n##\n(\"entity\"<|>NUTRITIONAL SUPPLEMENTATION<|>EVENT<|>Nutritional supplementation refers to the process of providing nutrients to individuals, particularly those with specific health conditions like chronic liver disease, to improve their health outcomes.)\n##\n(\"entity\"<|>HEPATITIS RESEARCH<|>ORGANIZATION<|>Hepatitis Research is an organization focused on studying hepatitis and its effects on liver health, including treatment and management strategies.)\n##\n(\"entity\"<|>JOURNAL OF HEPATOLOGY<|>ORGANIZATION<|>The Journal of Hepatology is a scientific journal that publishes research articles related to liver diseases, including hepatitis and cirrhosis.)\n##\n(\"entity\"<|>AUSTRALIAN MEDICAL JOURNAL<|>ORGANIZATION<|>The Australian Medical Journal is a peer-reviewed medical journal that publishes research and reviews on various medical topics, including liver health.)\n##\n(\"entity\"<|>MJA<|>ORGANIZATION<|>MJA stands for the Medical Journal of Australia, which publishes research and reviews on health issues affecting Australians, including liver diseases.)\n##\n(\"entity\"<|>BRITISH MEDICAL JOURNAL<|>ORGANIZATION<|>The British Medical Journal is a leading medical journal that publishes research articles and reviews on a wide range of medical topics, including liver health and nutrition.)\n##\n(\"entity\"<|>NUTRITION CLINICAL PRACTICE<|>ORGANIZATION<|>Nutrition Clinical Practice is a journal that focuses on the clinical aspects of nutrition and its impact on health, including liver diseases.)\n##\n(\"relationship\"<|>HEPATITIS<|>LIVER CIRRHOSIS<|>Hepatitis can lead to liver cirrhosis as a complication of chronic liver inflammation<|>8)\n##\n(\"relationship\"<|>NUTRITIONAL SUPPLEMENTATION<|>LIVER CIRRHOSIS<|>Nutritional supplementation is often used to improve the health of patients with liver cirrhosis<|>7)\n##\n(\"relationship\"<|>HEPATITIS RESEARCH<|>JOURNAL OF HEPATOLOGY<|>Hepatitis Research publishes studies and findings related to liver diseases, including those found in the Journal of Hepatology<|>6)\n##\n(\"relationship\"<|>AUSTRALIAN MEDICAL JOURNAL<|>NUTRITION CLINICAL PRACTICE<|>Both journals publish research related to nutrition and its effects on liver health<|>5)\n##\n(\"relationship\"<|>MJA<|>BRITISH MEDICAL JOURNAL<|>Both MJA and the British Medical Journal publish articles on medical research, including studies on liver diseases<|>5)\n##\n(\"relationship\"<|>NUTRITIONAL SUPPLEMENTATION<|>HEPATITIS RESEARCH<|>Nutritional supplementation is a key area of research for organizations focused on hepatitis and liver health<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: hy A, Ross R, Gimson A, Hughes SC, Holly J, Williams Nompleggi DJ, Bonkovsky HL. Nutritional supplementation in chronic liver disease: an analytical review. Hepatology 1994; 19:518-3.\n\n120. Miwa Y, Shiraki M, Kato M, Tajika M, Mohri H, Murakami N, et al. Improvement of fuel metabolism by nocturnal energy supplementation in patients with liver cirrhosis. Hepatology Research 2000 ;18(3):184-189.\n\n121. Chang WK, Chao YC, Tang HS, Lang HF, Hsu CT. Effects of extra-carbohydrate supplementation in the late evening on energy expenditure and substrate oxidation in patients with liver cirrhosis. JPEN 1997;21:96-9.\n\n122. Yamauchi M, Takeda K, Sakamoto K, Ohata M, Toda G. Effect of oral branched chain amino acid supplementation in the late evening on the nutritional state of patients with liver cirrhosis. Hepatol Res 2001;21:199-204.\n\n123. Tsuchiya M1, Sakaida I, Okamoto M, Okita K. The effect of a late evening snack in patients with liver cirrhosis.Hepatol Res. 2005;31(2):95-103.\n\n124. Okamoto M, Sakaida I, Tsuchiya M, Suzuki C, Okita K. Effect of a late evening snack on the blood glucose level and energy metabolism in patients with liver cirrhosis. Hepatology Research 27 (2003) 45-50.\n\n125. Swart GR, Zillikens MC, Van Vuure JK, Van den Berg JWO. Effect of late evening meal on nitrogen balance in patients with cirrhosis of the liver. Br Med J 1989; 299:1202-1203.\n\n126. Aoyama K, Tsuchiya M, Mori K, et al. Effect of a late evening snack on outpatients with liver cirrhosis. Hepatology Research. 2007; 37(8):608-614.\n\n127. Tsien CD, McCullough AJ, Dasarathy S. Late evening snack: exploiting a period of anabolic opportunity in cirrhosis. J Gastroenterol Hepatol. 2012; 27(3):430-41.\n\n128. Gu XB, Yang XJ, Zhu HY, Xu BY. Effect of a diet with unrestricted sodium on ascites in patients with hepatic cirrhosis. Gut Liver 2012; 6:355-361\n\n129. Zhu YF, Gu XB, Zhu HY, Yang XJ, Wang D, Yu P. Influence of non-sodium restricted diet with diuretics on plasma renin, renal blood flow and in patients with cirrhotic ascites. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2013; 27(1):50-3.\n\n130. Walbaum B, Valda ML, Rada G. Sodium restriction in patients with cirrhotic ascites: a protocol for a systematic review. Syst Rev. 2016;5:78.\n\n131. Soulsby CT, Madden AM, Morgan MY. The effect of dietary sodium restriction on energy and protein intake in patients with cirrhosis. Hepatology 1997; 26(Suppl 382A):S11.\n\n132. Seymour CA, Whelan K. Dietary management of hepatic encephalopathy. Too many myths persist. Br Med J 1999; 318:1364-1365.\n---\n# BLOQUE: PROTEÍNAS Y AMINOÁCIDOS\n\n133. Heyman JK, Whitfield CJ, Brock KE, McCaughan GW, Donaghy AJ. Dietary protein intakes in patients with hepatic encephalopathy and cirrhosis: current practice in NSW and ACT. MJA 2006; 185:542-3.\n\n134. Cabral CM, Burns DL. Low-protein diets for hepatic encephalopathy debunked: let them eat steak. Nutr Clin Pract. 2011; 26(2):155-9.\n\n135. Córdoba J, López-Hellín J, Planas M , Sabín P, Sanpedro F , Castro F, et al. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. Journal of hepatology 2004;41(1):38-43.\n\n136. Gluud LL, Dam G, Les I, Cordoba J, Marchesini G, Borre M, et al. Branchedchain amino acids for people with hepatic encephalopathy. CochraneD atabase Syst Rev 2015;9:CD001939.\n\n137. Tsien C, Davuluri G, Singh D, Allawy A, Ten Have GA, Thapaliya S, et al. Metabolic and molecular responses to leucine-enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis. Hepatology 2015; 61:2018-2029.\n\n138. Lieber C S. Alcohol, liver, and nutrition. J Am Coll Nutr 1991; 10:602-632.\n\n139. Rodriguez-Keiserman D, Aranda-Michel J, Weber FL Jr, et al. Bone Loss is Common in Both Cholestatic and Non-Cholestatic End Stage Liver Disease. DDW, San Francisco, CA, 2002.\n\n140. Ukleja A, Scolapio JS, McConnell JP, et al\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}